Old Web
English
Sign In
Acemap
>
authorDetail
>
Julie Chandler
Julie Chandler
Eli Lilly and Company
Pediatrics
Disease
Medicine
Mild dementia
disease progression
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Health care utilization patterns in early symptomatic AD prior to enrolment into Phase 2/3 clinical trial AMARANTH
2021
Julie Chandler
Jennifer A. Zimmer
Emily Kubisiak
Joanna M. Kubisiak
Show All
Source
Cite
Save
Citations (0)
Disease progression and costs at two‐year follow‐up of GERAS‐US: A three‐year study of mild cognitive impairment and mild dementia due to Alzheimer’s disease in the United States: Supportive and therapeutic environments
2020
Alzheimers & Dementia
Julie Chandler
Anthony Zagar
Yongin Kim
Jennifer A. Zimmer
Dorene M. Rentz
Ronald L. Schwartz
Howard Fillit
Show All
Source
Cite
Save
Citations (0)
1